Role of EEG as a monitoring tool in patients with glucose transporter type I deficiency syndrome (GLUT1‐DS) on ketogenic diet
Epileptic Disorders2023Vol. 25(3), pp. 360–370
Citations Over Time
Abstract
Ketogenic diet is the choice treatment for patients with GLUT1-DS. Electrographic features could show worsening after initiation of the ketogenic diet even with seizure control. EEG did not prove to be a reliable tool for adjusting KD in our cohort. Centrotemporal spikes have not been reported in patients with GLUT-1 DS.
Related Papers
- → Glucose Transporter Asymmetries in the Bovine Blood-Brain Barrier(2001)100 cited
- → High concentration of glucose decreases glucose transporter-1 expression in mouse placenta in vitro and in vivo(1999)42 cited
- → [The role of glucose transporter 1 (GLUT1) in the diagnosis and therapy of tumors].(2012)17 cited
- → Abstract 1442: Effects of selective and broad glucose transporter (GLUT) inhibition on glucose distribution in tumor bearing mice(2014)
- → Glucose Uptake in Heterologous Expression Systems(2017)